Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 8 Carcinoma, Non-Small-Cell Lung 7 Sarcoma 3 Thyroid Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Cancer Extensive Stage 1 Proteinuria 1 Platinum-resistant Ovarian Cancer (PROC) 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Fallopian Tube Neoplasms 1 Extensive Stage Lung Small Cell Cancer 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

anlotinib 1 Observation 1 Epirubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Adenoid Cystic × anlotinib × Clear all

NCT07616141 2026-06-01

NAET4-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Not yet recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡